| Followers | 200 |
| Posts | 25597 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Tuesday, November 28, 2023 5:11:26 PM
She has invested large sums, her own time and credibility in many ways to ensure this technology and this venture succeeds without interference that might have taken it down. And now you acknowledge she owns a substantial stake, yet she allows other shareholders to determine hers and the management’s fate.
The reason I like management in small companies to hold such stakes, and it is actually not typical but I disagree that she got it “free”, is because they have enough skin in the game that they are not typically going to sell other shareholders out to get in with big pharma and just get paid.
So I am definitely OK with LP, her dedication and determination to get this approved. I think investors that do not see that as an incredible plus are missing a major part of the big picture here.
It is amazing how you can completely contradict yourself just a few posts after this discussion started, and not even notice. She doesn’t own any equity now it is outrageous how much she owns… make up your mind!
The reason I like management in small companies to hold such stakes, and it is actually not typical but I disagree that she got it “free”, is because they have enough skin in the game that they are not typically going to sell other shareholders out to get in with big pharma and just get paid.
So I am definitely OK with LP, her dedication and determination to get this approved. I think investors that do not see that as an incredible plus are missing a major part of the big picture here.
It is amazing how you can completely contradict yourself just a few posts after this discussion started, and not even notice. She doesn’t own any equity now it is outrageous how much she owns… make up your mind!
I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
